Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

10% Pentastarch Versus 5% Albumin Solution for Volume Expansion Following Cariopulmonary Bypass in Patients Undergoing Open Heart Surgery

개심수술후 혈량 증가를 위한 10% Pentastarch와 5% Albumin 용액의 비교연구

  • Published : 1994.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Pentastarch is a hydroxyethyl starch similar to hetastarch, but lower average molecular weight and fewer hydroxyethyl groups which result in enhanced enzymatic hydrolysis and faster renal elimination.This report was performed to compare the clinical efficacy and safety of 10 % pentastarch[Pentaspan , group I] for plasma volume expansion after open heart surgery with that of 5% albumin[Plasmanate, group II]. There were no statistically significant differences between the group I [n=18] and group II [n:19] in the preoperative parameters [age, sex, body weight] and operative parameters[bypass time, aorta cross clamping time]. During the first 24 hours after arrival of the patient in the surgical intensive care unit, colloid solution [500--1000 ml] was infused to maintain left atrial pressure of more than 8 mmHg, or cardiac index of 2.0 L/min/M2 of more. In results, there were 3 complications of hypotension immediately after infusion of 5 % albumin solution and 2 among the 3 patients were excluded for the study. However there was no complication after infusion of 10 % pentastarch solution. Hemodynamic responses to infusion was similar for both groups, although in group I a greater increase in both left atrial pressure[mean 1.8 versus 0.7 mmHg, p< 0.05] and right atrial pressure [mean 2.2 versus 1.7 mmHg, p < 0.05] was observed during infusion of the first 500 ml. There were no significant differences in any of the measured respiratory parameters[PaO2, intrapulmonary shunt, and effective lung compliance]. Homodilution with colloid significantly reduced hemoglobin [mean 1.2 versus 0.8 gm/dl], and serum protein and albumin level[total protein;4.8$\pm$ 0.5 versus 5.2 $\pm$0.5 gm/dl, p < 0.05: albumin: 3.2 $\pm$0.4 versus 3.6 $\pm$0.6 gm/dl, p < 0.05] by 6:00 AM on 1 day postoperatively, however there were no significant differences on 7 day postoperatively. The mean serum colloid osmotic pressure and osmolarity was similar in both group.There were no abnormal findings of liver function and kidney function in all the patients. There were no significant between-group differences in bleeding time, platelets, prothrombin time, activated partial thromboplastin time and amount of chest tube output measured on 1st and 7th postoperative day. These findings demonstrated that 10% pentastarch is more effective and safe for plasma volume expension than 5 % albumin solution with no adverse effects on coagulation. Also 10 % pentastarch is less expensive than 5 % albumin and it would appeare to be a reasonable first choice for plasma volume expansion.

Keywords

References

  1. Proc Soc Exp Biol Med v.115 Bleeding volume indices of hydroxyethyl starch, dextran, blood, and glucose Thompson,W.L.;Wayt,D.H.;Walton,R.P.
  2. Transfusion v.27 Selecting the optimal dose of low-molecular weight hydroxyethyl starch(Pentastarch) for granulocyte collection Strauss,R.G.;Villhauer,P.J.;Imig,K.M.(et al.)
  3. Transfusion v.28 Pentastarch may cause fewer effects on coagulation than hetastarch Strauss,R.G.;Stanfield,C.;Henriksen,R.A.;Villhauer,P.J.
  4. J Thorac Cardiovasc Surg v.97 A randomized clinical trial of 10% pentastarch(low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations London,M.J.;Ho,J.S.;Triedman,J.K.(et al.)
  5. Crit Care Med v.17 Comparison of hydroxyl starch and lactated Ringer's solution on hemodynamics and oxygen transport of critically ill patients in prospective cross over studies Hankein,K.;Radel,C.;Beez,M.(et al.)
  6. 대흉외지 v.25 개심수술후 수술전 자가헌혈을 이용한 자가수혈의 효과 김동관;장병철;김현옥;권오헌;강면식;조범구
  7. New Engl J Med v.317 no.18 Transmission of the human immunodeficiency virus Friedland,G.H.;Klein,R.S.
  8. Ann Surg v.190 no.3 Vasodilator effects of the sodium acetate in pooled protein fraction Olinger,G.N.;Werner,P.H.;Bonchek,L.I.;Boerboom,L.E.
  9. Ann Thorac Surg v.33 no.3 Correlation of hypotensive effect of plasma protein fraction with prekallikrein activator activity: A clinical study in patients having openheart surgery Heinonen,J.;Peltola,K.;Himberg,J.J.;Suomela,H.
  10. J Clin Apheresis v.1 Dosage and scheduling regimens for erythrocyte sedimenting macromolecules Mishler,J.M.;Hester,J.P.;Heustis,D.W.;Rock,G.A.;Strauss,R.G.
  11. Ann Thorac Surg v.34 Clinical comparison of hetastarch and albumin in postoperative cardiac patients Diehl,J.T.;Lester,J.L.;Cosgrove,D.M.
  12. Ann Thorac Surg v.37 Hydroxyethyl starch versus albumin of colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization Kirklin,J.K.;Lell,W.A.;Kouchoukos,N.T.
  13. J Clin Pharmacol v.22 Pharmacokinetics of hydroxyethyl starch in normal subjects Yacobi,A.;Stoll,R.G.;Sum,C.Y.;Lai,C.A.;Gupta,S.D.;Hulse,J.D.
  14. Clinical applications of blood gases(3rd ed.) Shapiro,B.A.;Harrison,R.A.;Walton,J.
  15. Respiratory care: a guide to clinical practice Burton,G.G.;Gee,G.N.;Hodgkin,J.E.
  16. Med J Aust v.2 Hypotensive effects of stable plasma prote in solution(SPPS): a preliminary communication Harrison,G.A.McCulloch,C.H.;Robinson,M.(et al.)
  17. N Engl J Med v.286 Hypotension due to 5 per cent plasma protein fractions Bland,J.H.L.;Laver,M.B.;Lowenstein,E.
  18. Crit Care Med v.17 Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion Rackow,E.C.;Mecker,C.;Astiz,M.E.(et al.)